Abstract P2-11-16: Distribution of G-protein coupled estrogen receptor in treatment-naïve triple negative breast cancer and association with clinicopathologic characteristics
Sneha Phadke(University of Iowa Hospitals and Clinics), Edward J. Filardo(University of Iowa), Andrew M. Bellizzi(University of Iowa), Murray B. Resnick(Brown University), Amani Bashir(University of Iowa), Ashlee Sturtevant(Rhode Island Hospital), Sarah L. Mott(University of Iowa Holden Comprehensive Cancer Center)
Cited by 3
Related Papers
Identity of an Estrogen Membrane Receptor Coupled to a G Protein in Human Breast Cancer Cells
|Endocrinology|2004|1.4k
Estrogen-Induced Activation of Erk-1 and Erk-2 Requires the G Protein-Coupled Receptor Homolog, GPR30, and Occurs via Trans-Activation of the Epidermal Growth Factor Receptor through Release of HB-EGF
|Molecular Endocrinology|2000|1.3k
Estrogen Action Via the G Protein-Coupled Receptor, GPR30: Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis
|Molecular Endocrinology|2002|854
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
|British Journal of Pharmacology|2021|488